VA Disability for Fibromyalgia Secondary to PTSD: Mechanism and Evidence (2026)

Why Fibromyalgia Is Recognized as Secondary to PTSD

Fibromyalgia is now understood as a central nervous system disorder of pain processing rather than a peripheral musculoskeletal disease. The defining feature is amplified pain perception arising from central sensitization — a state in which the spinal cord and brain become more responsive to all incoming nociceptive signals. Trauma, chronic stress, and conditions that produce sustained autonomic and HPA axis activation are recognized triggers for central sensitization.

Multiple studies have demonstrated that veterans with PTSD have fibromyalgia prevalence rates substantially higher than non-PTSD veterans or the general population. The relationship is dose-dependent — more severe PTSD is associated with higher fibromyalgia risk — and is supported by shared neurobiological mechanisms.

Central Sensitization: The Core Mechanism

Central sensitization refers to enhanced responsiveness of nociceptive neurons in the central nervous system. In a sensitized state, normal stimuli are perceived as painful (allodynia), painful stimuli are perceived as more painful (hyperalgesia), and pain may persist after the original stimulus has resolved.

How PTSD Drives Central Sensitization

PTSD produces sustained alterations in central nervous system function — particularly in the limbic system, anterior cingulate cortex, insula, and amygdala. These same regions are involved in pain processing. Chronic activation of stress and threat circuits cross-talks with descending pain modulation pathways, reducing the brain's ability to dampen incoming pain signals. The result is amplified central pain processing.

Neurotransmitter Changes

PTSD is associated with dysregulation of serotonin, norepinephrine, and substance P — neurotransmitters that play key roles in descending pain modulation. Reduced serotonergic and noradrenergic tone in the descending pain inhibition pathways allows nociceptive signals to be amplified at the spinal cord level.

Imaging Evidence

Functional neuroimaging studies of fibromyalgia patients show altered activation in pain-processing regions and altered functional connectivity between those regions and emotion-processing regions — overlapping patterns with PTSD imaging studies.

HPA Axis and Autonomic Contributions

Beyond central sensitization, several other PTSD-related mechanisms contribute to fibromyalgia.

HPA Axis Dysregulation

Chronic stress alters HPA axis function. Some patients show chronically elevated cortisol; others develop blunted cortisol responses. Both patterns are associated with widespread pain syndromes. The HPA axis also influences inflammation, energy metabolism, and sleep — all of which are disrupted in fibromyalgia.

Autonomic Nervous System Dysfunction

Sustained sympathetic hyperactivity and reduced parasympathetic tone — the autonomic signature of PTSD — contribute to muscle tension, autonomic symptoms (palpitations, dizziness, GI dysfunction), and altered pain modulation. Heart rate variability studies in fibromyalgia patients consistently show reduced parasympathetic activity.

Sleep Architecture Disruption

PTSD disrupts sleep architecture, particularly deep slow-wave sleep that is essential for pain modulation, tissue restoration, and growth hormone release. Sleep deprivation alone can produce fibromyalgia-like symptoms in healthy individuals, and most fibromyalgia patients have abnormal sleep architecture.

Neuroinflammation

Both PTSD and fibromyalgia involve elevated inflammatory markers and altered glial cell activation in the central nervous system. The neuroinflammatory hypothesis links the two conditions at the molecular level.

Diagnosing Fibromyalgia (ACR 2016 Criteria)

The American College of Rheumatology revised the fibromyalgia diagnostic criteria in 2016 (preliminary 2010, revised 2011 and 2016). The current criteria do not require tender point examination.

Required Criteria

• Widespread Pain Index (WPI) score of at least 7 with Symptom Severity Scale (SSS) score of at least 5, OR WPI of 4–6 with SSS of at least 9.
• Generalized pain — present in at least 4 of 5 body regions (left upper, right upper, left lower, right lower, axial).
• Symptoms present at a similar level for at least 3 months.
• A diagnosis of fibromyalgia is valid irrespective of other diagnoses; it does not exclude the presence of other clinically important illnesses.

Widespread Pain Index

The WPI is a 0–19 scale counting the number of body areas (out of 19 specific regions) in which the patient has experienced pain over the past week.

Symptom Severity Scale

The SSS evaluates fatigue, waking unrefreshed, and cognitive symptoms (each 0–3) plus the presence of additional somatic symptoms (0–3), totaling 0–12.

Distinguishing From Other Conditions

The diagnosis is clinical. Laboratory and imaging tests are used to rule out alternative diagnoses (rheumatoid arthritis, lupus, hypothyroidism, polymyalgia rheumatica) rather than to confirm fibromyalgia itself. Normal laboratory studies are consistent with — not against — the diagnosis.

Rating Under DC 5025

Fibromyalgia is rated under 38 CFR 4.71a, Diagnostic Code 5025 (fibromyalgia, fibrositis, primary fibromyalgia syndrome).

40 Percent

Widespread musculoskeletal pain and tender points, with or without associated fatigue, sleep disturbance, stiffness, paresthesias, headache, irritable bowel symptoms, depression, anxiety, or Raynaud's-like symptoms — that are constant, or nearly so, and refractory to therapy.

20 Percent

Same symptoms — episodic, with exacerbations often precipitated by environmental or emotional stress or by overexertion, but that are present more than one-third of the time.

10 Percent

Same symptoms — that require continuous medication for control.

The DC 5025 rating analysis emphasizes the constancy and severity of symptoms rather than tender point counts. A 40 percent rating requires "constant, or nearly so" symptoms that are refractory to treatment.

The Fibromyalgia Symptom Cluster

DC 5025 specifically references the broad symptom cluster that defines fibromyalgia, recognizing that pain is just one component. The complete cluster includes:

• Widespread musculoskeletal pain — bilateral, upper and lower body, often axial.
• Tender points or tenderness — historically central to diagnosis, now less emphasized.
• Fatigue — non-restorative sleep, daytime exhaustion.
• Sleep disturbance — difficulty falling asleep, frequent awakenings, non-refreshing sleep.
• Stiffness — particularly morning stiffness, often improving with activity.
• Paresthesias — tingling, numbness in extremities.
• Headache — tension-type or migraine.
• Irritable bowel symptoms — overlapping with the IBS-secondary-to-PTSD pathway.
• Depression and anxiety — independently rated when separately service-connected.
• Raynaud's-like symptoms — cold-induced color changes, less common.
• Cognitive symptoms ("fibro fog") — concentration difficulties, memory complaints.

The presence and severity of these associated symptoms support both the diagnosis and the rating analysis.

Gulf War Veterans and Presumptive Considerations

For veterans who served in the Persian Gulf or other Southwest Asia theater of operations, fibromyalgia may also qualify for presumptive service connection as a chronic multisymptom illness under 38 CFR 3.317. Presumptive analysis runs alongside (not instead of) secondary service connection analysis. Veterans whose fibromyalgia could qualify under either pathway often pursue both, since the strongest evidentiary basis can support the rating analysis regardless of which legal theory applies.

Evidence Required for the Claim

A defensible fibromyalgia-secondary-to-PTSD claim typically rests on the following evidence.

Existing PTSD Service Connection

The PTSD service connection must be established. The PTSD rating decision and current rating provide the foundation.

Fibromyalgia Diagnosis

Diagnosis by a rheumatologist, primary care physician, or other qualified clinician using current ACR criteria. Records should document WPI and SSS scores, the widespread pain pattern, and the rule-out of alternative diagnoses.

Symptom Documentation

Records describing the full symptom cluster — pain, fatigue, sleep disturbance, cognitive symptoms — over time. A patient symptom diary is useful for the rating analysis.

Treatment History

Records of pharmacotherapy (duloxetine, milnacipran, pregabalin, gabapentin, low-dose amitriptyline), non-pharmacologic interventions (graded exercise, cognitive behavioral therapy, physical therapy), and treatment response.

Temporal Documentation

Records establishing the chronological relationship between PTSD onset/worsening and the emergence of fibromyalgia symptoms.

Lay Statements

Statements from the veteran, spouse, family, or coworkers describing the impact of pain and fatigue on daily functioning.

Medical Nexus Opinion

A licensed physician's opinion articulating the central sensitization mechanism connecting PTSD to fibromyalgia, using the "at least as likely as not" standard, and citing the relevant clinical literature.

Building the Nexus Letter

A defensible nexus letter for fibromyalgia secondary to PTSD contains the following elements.

Identification of the Service-Connected PTSD

The letter should reference the PTSD service connection, current rating, severity, and any relevant treatment history.

Current Fibromyalgia Diagnosis

The letter should identify the fibromyalgia diagnosis with reference to ACR criteria (WPI, SSS, widespread pain in 4 of 5 regions, three-month duration), the work-up performed to exclude alternative diagnoses, and the full symptom cluster present in this veteran.

Central Sensitization Mechanism

The opinion should articulate the central sensitization mechanism — how chronic PTSD-related stress alters descending pain modulation, neurotransmitter regulation, HPA axis function, autonomic balance, and sleep architecture to produce widespread amplified pain perception.

Causation or Aggravation Specification

Whether PTSD caused new-onset fibromyalgia or aggravated a pre-existing condition. For aggravation, baseline and increment should be characterized.

"At Least as Likely as Not" Language

The opinion must use the VA's required threshold.

Records-Based Review

The letter should affirm review of the PTSD records, rheumatology evaluation, treatment history, and any laboratory work-up before forming the opinion.